Observational, Multi-Center Study of the Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian Federation
Clinical trial NCT02669940 · COMPLETED
Trial details
- NCT number
- NCT02669940
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-04-15
- Primary completion
- 2017-07-04
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.